Dr. Amy Sanders is a board-certified neurologist, specializing in dementia and cognitive decline. After graduating medical school and completing her Fellowship in Dementia from Albert Einstein College of Medicine, Dr. Sanders became an early member of the Clinical and Neuropathological Cores of the Einstein Aging Study, an NIA-funded grant. Among her many achievements, she became a lead writer on this grant, become inaugural Chair for the Neurology department Quality Committee, and served as PI on multiple Alzheimer’s drug trial studies. She continued her career as Medical Director and Associate Professor of Neurology at Hartford Healthcare, leading an innovative team of ten interdisciplinary professionals for Alzheimer’s and related dementias, maintaining leadership through a surge in patient volume.

Dr. Sanders has complemented her robust clinical experiences with a long history of clinical education, consulting, and editing, including at StatPearls where she regularly reviews and edits content. She has also authored more than 25 peer-reviewed scientific communications and has a Master’s degree in Clinical Research Methods.

Dr. Sara Doyle is double board-certified in psychiatry and neurology as well as in preventive medicine and has nearly a decade of clinical experience. After completing her training at the University of Rochester School of Medicine, she worked as a Neurohospitalist where she managed extensive neurological conditions and emergencies and was responsible for overseeing all admissions to the inpatient units. She currently practices at the University of Texas Health - San Antonio, providing both inpatient and outpatient care.

Dr. Doyle has multiple publications focused on neurological disorders, prevention, and brain function including public health explorations of brain health and perception.

Dr. Doug Elwood is an executive physician and serial entrepreneur with nearly 20 years experience in digital health, innovative care models, enhancing access, and scaling clinical programs.

Dr. Elwood was the first hire and spent seven years as Chief Medical Officer at PWNHealth, growing the company into an international leader in genetics, telehealth, and diagnostics. The company was live in all 50 states and parts of Canada, worked with a myriad of Fortune 500 and innovative health companies, and completed millions of visits and tests per year. Under Dr. Elwood’s clinical leadership, PWN became the gold standard in multiple areas including closing gaps in care, early disease identification, emerging genetics like liquid biopsy and PRS, and Covid.Dr.

Elwood has also served as Executive Advisor, fractional CMO, PC owner, and board committee member to half a dozen cutting-edge health and wellness companies that represent a broad spectrum of emerging trends including AI, haptic sensors, addiction, and adherence. He also spent nearly two years as co-founder and CEO of EnSage, focused on building multidisciplinary care teams for patients with moderate to severe dementia and securing a risk-based contract with a national provider group as well as a national and regional payer. An author of dozens of peer-reviewed articles and abstracts, Dr. Elwood has consulted to multiple companies throughout the industry in care management and early identification programs.

Maria Thomas brings a unique blend of consumer insight, operational rigor, and healthcare innovation to building scalable, trusted care models. Over her multi-decade career, she has earned a reputation for creating exceptional consumer experiences, lasting business models, and cost-efficient growth through diverse acquisition strategies across industries.

Before co-founding Sunday Health, Maria played a key role in launching DUOS, a Redesign Health company that provides health plans with AI-driven solutions to address the needs of older adults. She also served as an advisor to Alive Ventures, a for-profit spinout of the SCAN Foundation focused on supporting entrepreneurs developing tailored products and services for aging populations.

Maria previously served as Etsy's first non-founder CEO, leading the company through a period of extraordinary growth—from a small, early-stage startup to an iconic global brand and e-commerce platform serving seven million customers and generating approximately $350 million in gross merchandise sales.

She holds an MBA from Northwestern University's Kellogg School, a Master’s in Healthcare Innovation from the University of Pennsylvania, and a BS in Accounting from Boston University.